$ARRY
Array Technologies, Inc. Stock $arry

$arry Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000182072123000099 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$507.7M	$376.8M
YoY Change	19.48%	25.35%
Cost Of Revenue	$357.7M	$275.6M
YoY Change	-5.26%	0.58%
Gross Profit	$150.0M	$101.2M
YoY Change	216.7%	280.56%
Gross Profit Margin	29.55%	26.85%
Selling, General & Admin	$40.25M	$38.14M
YoY Change	27.74%	-4.23%
% of Gross Profit	26.83%	37.7%
Research & Development	$2.300M	$2.100M
YoY Change
% of Gross Profit	1.53%	2.08%
Depreciation & Amortization	$13.16M	$14.53M
YoY Change	-46.41%	-36.88%
% of Gross Profit	8.77%	14.36%
Operating Expenses	$53.80M	$53.72M
YoY Change	-3.75%	-8.56%
Operating Profit	$96.24M	$47.46M
YoY Change	-1229.32%	-247.56%
Interest Expense	-$9.155M	$9.500M
YoY Change	-6.17%	36.85%
% of Operating Profit	-9.51%	20.02%
Other Income/Expense, Net	$125.0K	-$11.45M
YoY Change	-133.69%	390.15%
Pretax Income	$87.21M	$36.01M
YoY Change	-613.85%	-204.38%
Income Tax	$22.40M	$9.900M
% Of Pretax Income	25.69%	27.49%
Net Earnings	$52.02M	$26.13M
YoY Change	-1973.39%	-218.49%
Net Earnings / Revenue	10.25%	6.94%
Basic Earnings Per Share	$0.34	$0.09
Diluted Earnings Per Share	$0.34	$0.09
COMMON SHARES
Basic Shares Outstanding	150.9M shares	150.8M shares
Diluted Shares Outstanding	152.1M shares	151.8M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$156.0M	$147.8M
YoY Change	205.54%	198.55%
Cash & Equivalents	$156.0M	$147.8M
Short-Term Investments
Other Short-Term Assets	$42.74M	$46.38M
YoY Change	-19.1%	-0.25%
Inventory	$206.9M	$254.6M
Prepaid Expenses
Receivables	$502.4M	$414.7M
Other Receivables	$312.0K	$3.163M
Total Short-Term Assets	$908.2M	$866.6M
YoY Change	0.03%	6.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.67M	$25.86M
YoY Change	72.31%	53.24%
Goodwill	$441.3M	$428.2M
YoY Change	5.64%	12.72%
Intangibles	$375.5M	$379.4M
YoY Change	-13.98%	-19.4%
Long-Term Investments
YoY Change
Other Assets	$97.09M	$30.80M
YoY Change	97.76%	-1.64%
Total Long-Term Assets	$944.5M	$927.5M
YoY Change	8.89%	3.21%
TOTAL ASSETS
Total Short-Term Assets	$908.2M	$866.6M
Total Long-Term Assets	$944.5M	$927.5M
Total Assets	$1.853B	$1.794B
YoY Change	4.36%	4.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$188.6M	$200.6M
YoY Change	-18.79%	7.0%
Accrued Expenses	$62.70M	$60.24M
YoY Change	2.9%	-12.6%
Deferred Revenue	$114.8M	$151.3M
YoY Change	-31.48%	24.44%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$37.45M	$34.38M
YoY Change	-27.27%	-28.64%
Total Short-Term Liabilities	$435.0M	$470.6M
YoY Change	-15.59%	8.65%
LONG-TERM LIABILITIES
Long-Term Debt	$702.5M	$705.8M
YoY Change	-11.93%	-9.31%
Other Long-Term Liabilities	$28.15M	$13.94M
YoY Change	61.71%	96.27%
Total Long-Term Liabilities	$730.6M	$719.8M
YoY Change	-10.35%	-19.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$435.0M	$470.6M
Total Long-Term Liabilities	$730.6M	$719.8M
Total Liabilities	$1.240B	$1.275B
YoY Change	-12.34%	-3.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$176.5M	-$241.3M
YoY Change	-41.71%	-17.9%
Common Stock	$151.0K	$150.0K
YoY Change	0.67%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$612.3M	$207.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.853B	$1.794B
YoY Change	4.36%	4.57%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$52.02M	$26.13M
YoY Change	-1973.39%	-218.49%
Depreciation, Depletion And Amortization	$13.16M	$14.53M
YoY Change	-46.41%	-36.88%
Cash From Operating Activities	$20.54M	$45.82M
YoY Change	-292.56%	-191.45%
INVESTING ACTIVITIES
Capital Expenditures	$5.541M	$3.883M
YoY Change	-460.27%	64.74%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$5.541M	-$3.883M
YoY Change	259.81%	-98.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-15.55M	-$23.76M
YoY Change	-170.82%	-123.59%
NET CHANGE
Cash From Operating Activities	20.54M	$45.82M
Cash From Investing Activities	-5.541M	-$3.883M
Cash From Financing Activities	-15.55M	-$23.76M
Net Change In Cash	-553.0K	$13.86M
YoY Change	-105.67%	-104.35%
FREE CASH FLOW
Cash From Operating Activities	$20.54M	$45.82M
Capital Expenditures	$5.541M	$3.883M
Free Cash Flow	$15.00M	$41.93M
YoY Change	-264.3%	-179.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001820721
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100736000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39613
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ARRAY TECHNOLOGIES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2747826
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3901 Midway Place NE
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Albuquerque
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87109
CY2023Q1	dei	City Area Code CityAreaCode	(505)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	881-7567
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	ARRY
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	150853116	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147756000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133901000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	414712000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421183000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	254624000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	233159000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3163000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3532000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46381000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39434000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	866636000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	831209000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25864000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23174000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	428173000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	416184000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	379374000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	386364000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16466000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	63320000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30802000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32655000	usd
CY2023Q1	us-gaap	Assets Assets	1794169000	usd
CY2022Q4	us-gaap	Assets Assets	1706052000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	200585000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	170430000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58795000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54895000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1443000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3690000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	11833000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	6881000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	151343000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	178922000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1811000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1200000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	34382000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	38691000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10393000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10553000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	470585000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	465262000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	73051000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	72606000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6914000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7387000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13939000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14808000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	4469000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1786000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	705827000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	720352000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1274785000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1282201000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	500000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	500000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	412739	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	406389	shares
CY2023Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	412700000	usd
CY2022Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	406400000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	312054000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	299570000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	150822974	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	150513104	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	150000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	150000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	426221000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	383176000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-241338000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-267470000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22297000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8425000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	207330000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	124281000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1794169000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1706052000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	376773000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300586000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	275594000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	273999000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	101179000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	26587000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38142000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45425000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1338000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3731000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14241000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23237000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	53721000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	64931000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	47458000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-38344000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	194000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	743000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-194000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3863000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1950000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9500000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	6942000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11450000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2336000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36008000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40680000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9876000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14743000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	26132000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25937000	usd
CY2023Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	12484000	usd
CY2022Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	11606000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13648000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37543000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150607000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	148288000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151795000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	148288000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	26132000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25937000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	13872000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	56675000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40004000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30738000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	406000	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	299570000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	124281000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3366000	usd
CY2023Q1	arry	Temporary Equity Accretion Of Dividends Shares TemporaryEquityAccretionOfDividendsShares	7000	shares
CY2023Q1	us-gaap	Temporary Equity Accretion Of Dividends TemporaryEquityAccretionOfDividends	12484000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13235000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	26132000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13872000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	413000	shares
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	312054000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	207330000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	350000	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	237462000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-69205000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4413000	usd
CY2022Q1	arry	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	50000	shares
CY2022Q1	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	32724000	usd
CY2022Q1	us-gaap	Temporary Equity Accretion Of Dividends TemporaryEquityAccretionOfDividends	11606000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	11606000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25937000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	56675000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	400000	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	281792000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	170218000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	26132000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25937000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	233000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	145000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4555000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4349000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14533000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23608000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2826000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1710000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3366000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4508000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1338000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3731000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	436000	usd
CY2022Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	594000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	1847000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	409000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1950000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6238000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	44268000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23312000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	46250000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-369000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	21924000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6947000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11558000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	30155000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	59419000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3900000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7027000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4952000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-8760000	usd
CY2023Q1	arry	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	824000	usd
CY2022Q1	arry	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	6085000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-27579000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-18639000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45816000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50097000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3883000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2357000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	373816000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3883000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-376173000	usd
CY2023Q1	arry	Proceeds From Issuance Of Temporary Equity ProceedsFromIssuanceOfTemporaryEquity	0	usd
CY2022Q1	arry	Proceeds From Issuance Of Temporary Equity ProceedsFromIssuanceOfTemporaryEquity	33098000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15885000	usd
CY2023Q1	arry	Payment Of Temporary Equity Issuance Costs PaymentOfTemporaryEquityIssuanceCosts	750000	usd
CY2022Q1	arry	Payment Of Temporary Equity Issuance Costs PaymentOfTemporaryEquityIssuanceCosts	175000	usd
CY2023Q1	arry	Payments Of Common Stock Issuance Costs PaymentsOfCommonStockIssuanceCosts	0	usd
CY2022Q1	arry	Payments Of Common Stock Issuance Costs PaymentsOfCommonStockIssuanceCosts	450000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	52000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	6469000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	6229000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	11075000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4368000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	17206000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023Q1	arry	Business Combination Contingent Consideration Arrangements Settlements Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsSettlementsOfContingentConsiderationLiability	1200000	usd
CY2022Q1	arry	Business Combination Contingent Consideration Arrangements Settlements Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsSettlementsOfContingentConsiderationLiability	1483000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23762000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4316000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7355000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13855000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-318179000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133901000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367670000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	147756000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49491000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7980000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3039000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2522000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	6350000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	6189000	usd
CY2023Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2022Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	200224000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization, Business and Out-of-Period Adjustments <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Array Technologies, Inc. (the “Company”), formerly ATI Intermediate Holdings, LLC, is a Delaware corporation formed in December 2018 as a wholly owned subsidiary of ATI Investment Parent, LLC (“Former Parent”). On October 14, 2020, the Company converted from a Delaware limited liability company to a Delaware corporation and changed the Company’s name to Array Technologies, Inc. The Company is headquartered in Albuquerque, New Mexico, and manufactures and supplies solar tracking systems and related products for customers across the United States and internationally. The Company, through its wholly-owned subsidiary, ATI Investment Sub, Inc. owns subsidiaries through which it conducts substantially all operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Acquisition of STI Norland</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">On January 11, 2022 (the “Acquisition Date”), the Company acquired 100% of the share capital of Soluciones Técnicas Integrales Norland, S.L.U., a Spanish private limited liability Company, and its subsidiaries (collectively, “STI”) with cash and common stock of the Company (the “STI Acquisition”). The STI Acquisition was accounted for as a business combination. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upon completion of the STI Acquisition, the Company began operating as two reportable operating segments: the Array legacy operating segment (the “Array Legacy Operations”) and the newly acquired operations (the “STI Operations”) pertaining to STI.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Out-of-Period Adjustment for the Correction of Errors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">During the first quarter of fiscal year 2023, the Company identified certain errors in its previously issued financial statements that have been corrected through a cumulative out-of-period adjustment in the condensed consolidated financial statements as of and for the three months ended March 31, 2023. The Company has concluded that the errors are not material to the previously issued financial statements and the cumulative out-of-period adjustment for the correction of these errors is not material to the financial statements for the three months ended March 31, 2023. Below is a summary of each of the errors corrected and a summary of the cumulative impact.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Capped Calls</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">As discussed in Note 8 – Debt, of the Company’s consolidated financial statements for the fiscal year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 22, 2023, in November 2021, the Company paid $52.9 million to enter into capped call option agreements (the “Capped Calls”) to reduce the potential dilution to holders of the Company’s common stock after a conversion of the Company’s Convertible Notes (as defined below). The Company originally concluded that the Capped Calls met the criteria for equity classification because the Capped Calls are indexed to the Company’s common stock, and the Company has discretion to settle the Capped Calls in shares or cash. As a result, the Company originally recorded the amount paid for the Capped Calls as a reduction to additional paid-in capital of $52.9 million, offset by $12.4 million of income taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">When the Company entered into the Capped Calls, the Company executed certain side letters (the “Side Letters”) with the counterparties that replaced some of the terms described in the primary contract including the volatility inputs used to value the Capped Calls under certain circumstances. Upon further evaluation, the Company has concluded that the modification to the volatility inputs precludes the Capped Calls from being </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">indexed to its own stock because there is the possibility that the Capped Calls will settle at an amount that exceeds fair value and, therefore, prevents the Capped Calls from being classified as equity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition, the Side Letters also provide for certain adjustments to settlement amounts on the basis of holder-specific taxes which are impermissible inputs to the valuation that also prevents the Capped Calls from being indexed to the Company’s own stock, and therefore, prevents the Capped Calls from being classified as equity. As a result, for the three months ended March 31, 2023, the Company has concluded that the cash paid for the Capped Calls should have been recorded as an asset of $52.9 million with the asset being subsequently marked to market at the end of each accounting period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Additional Closing Purchased Put Option</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">As discussed in Note 9 – Redeemable Perpetual Preferred Stock, of the Company’s consolidated financial statements for the fiscal year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 22, 2023, in August 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain Purchasers (as defined below), which gives the Company the option to require the Purchasers to purchase up to an additional 150,000 shares of Series A Shares (as defined below) and up to 3,375,000 shares of common stock for $148.0 million until June 30, 2023 (the “Put Option”). Upon issuance of the Put Option, the Company recorded a reduction to additional paid-in-capital of approximately $12.4 million because the Company originally concluded that the Put Option should be classified as equity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">During the first quarter of 2023, the Company reconsidered the provisions of this option. Because the Series A Shares underlying the Put Option could potentially require redemption under the Certificate of Designations governing the Series A Shares, the Put Option should not have been equity classified. As a result, during the three months ended March 31, 2023, the Company has concluded that the value of the Put Option at inception should have been recorded as an asset of $12.4 million, with the asset being subsequently marked to market at the end of each accounting period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Correction of the Capped Calls and Put Option </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The adjustments to correct the Capped Calls and the Put Option at January 1, 2023 resulted in an increase in Derivative assets of $55.7 million, a decrease in Deferred income tax assets of $11.0 million, an increase in additional paid-in-capital of $52.9 million, and a decrease in net income of $8.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In connection with the acquisition of STI, the Company had understated goodwill by $2.0 million and overstated inventory by the same amount that was sold during fiscal 2022. The Company corrected the goodwill balance during the current period resulting in an increase in goodwill and a decrease in cost of goods sold.</span></div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Use of Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements; however, management believes that these estimates and assumptions provide a reasonable basis for the fair presentation of the consolidated financial statements. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period they occur.</span></div>
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	88348000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	416785000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	423071000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2073000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1888000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	414712000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421183000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	66574000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	166276000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	166585000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	254624000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	233159000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43965000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40993000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18101000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17819000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25864000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23174000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	700000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	600000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	300000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	500000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	400000	usd
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	416184000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	9989000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	428173000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	610698000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	602432000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	241624000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	226368000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	369074000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	376064000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	379374000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	386364000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13800000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	34846000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	46970000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	46970000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	42664000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	38020000	usd
CY2023Q1	arry	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	159604000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	369074000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9900000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14700000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	42138000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	51951000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	768538000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	789426000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	28329000	usd
CY2023Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	12484000	usd
CY2022Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	11606000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	30383000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	740209000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	759043000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	34382000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	38691000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	705827000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	720352000	usd
CY2022Q1	arry	Percentage Of Variable Weighted Average Price Of Temporary Equity PercentageOfVariableWeightedAveragePriceOfTemporaryEquity	0.95
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	376773000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300586000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	122003000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	101513000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	151343000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	178922000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	125200000	usd
CY2023Q1	arry	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.70
CY2023Q1	arry	Revenue Bill And Hold Performance Obligation Amount RevenueBillAndHoldPerformanceObligationAmount	17600000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	571500000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	26132000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25937000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13648000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37543000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150607000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	148288000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1188000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151795000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	148288000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q1	arry	Incremental Common Shares Attributable To Anti Dilutive Effect Of Share Based Payment Arrangements IncrementalCommonSharesAttributableToAntiDilutiveEffectOfShareBasedPaymentArrangements	654277	shares
CY2023Q1	us-gaap	Other Borrowings OtherBorrowings	42100000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3300000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4400000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	32800000	usd
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	376773000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300586000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	101179000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	26587000	usd

Files In Submission

Name	View Source	Status
arry-20230331_lab.xml	Edgar Link	unprocessable
arry-20230331_def.xml	Edgar Link	unprocessable
arry-20230331_cal.xml	Edgar Link	unprocessable
0001820721-23-000099-index-headers.html	Edgar Link	pending
0001820721-23-000099-index.html	Edgar Link	pending
0001820721-23-000099.txt	Edgar Link	pending
0001820721-23-000099-xbrl.zip	Edgar Link	pending
arry-20230331.htm	Edgar Link	pending
arry-20230331.xsd	Edgar Link	pending
arry-20230331_g1.jpg	Edgar Link	pending
exhibit3112023q1.htm	Edgar Link	pending
exhibit3122023q1.htm	Edgar Link	pending
exhibit3212023q1.htm	Edgar Link	pending
exhibit3222023q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
i2amendmentno3tocreditag.htm	Edgar Link	pending
i2amendmentno3tocreditag001.jpg	Edgar Link	pending
i2amendmentno3tocreditag002.jpg	Edgar Link	pending
i2amendmentno3tocreditag003.jpg	Edgar Link	pending
i2amendmentno3tocreditag004.jpg	Edgar Link	pending
i2amendmentno3tocreditag005.jpg	Edgar Link	pending
i2amendmentno3tocreditag006.jpg	Edgar Link	pending
i2amendmentno3tocreditag007.jpg	Edgar Link	pending
i2amendmentno3tocreditag008.jpg	Edgar Link	pending
i2amendmentno3tocreditag009.jpg	Edgar Link	pending
i2amendmentno3tocreditag010.jpg	Edgar Link	pending
i2amendmentno3tocreditag011.jpg	Edgar Link	pending
i2amendmentno3tocreditag012.jpg	Edgar Link	pending
i2amendmentno3tocreditag013.jpg	Edgar Link	pending
i2amendmentno3tocreditag014.jpg	Edgar Link	pending
i2amendmentno3tocreditag015.jpg	Edgar Link	pending
i2amendmentno3tocreditag016.jpg	Edgar Link	pending
i2amendmentno3tocreditag017.jpg	Edgar Link	pending
i2amendmentno3tocreditag018.jpg	Edgar Link	pending
i2amendmentno3tocreditag019.jpg	Edgar Link	pending
i2amendmentno3tocreditag020.jpg	Edgar Link	pending
i2amendmentno3tocreditag021.jpg	Edgar Link	pending
i2amendmentno3tocreditag022.jpg	Edgar Link	pending
arry-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
arry-20230331_htm.xml	Edgar Link	completed
i2amendmentno3tocreditag023.jpg	Edgar Link	pending
i2amendmentno3tocreditag024.jpg	Edgar Link	pending
i2amendmentno3tocreditag025.jpg	Edgar Link	pending
i2amendmentno3tocreditag026.jpg	Edgar Link	pending
i2amendmentno3tocreditag027.jpg	Edgar Link	pending
i2amendmentno3tocreditag028.jpg	Edgar Link	pending
i2amendmentno3tocreditag029.jpg	Edgar Link	pending
i2amendmentno3tocreditag030.jpg	Edgar Link	pending
i2amendmentno3tocreditag031.jpg	Edgar Link	pending
i2amendmentno3tocreditag032.jpg	Edgar Link	pending
i2amendmentno3tocreditag033.jpg	Edgar Link	pending
i2amendmentno3tocreditag034.jpg	Edgar Link	pending
i2amendmentno3tocreditag035.jpg	Edgar Link	pending
i2amendmentno3tocreditag036.jpg	Edgar Link	pending
i2amendmentno3tocreditag037.jpg	Edgar Link	pending
i2amendmentno3tocreditag038.jpg	Edgar Link	pending
i2amendmentno3tocreditag039.jpg	Edgar Link	pending
i2amendmentno3tocreditag040.jpg	Edgar Link	pending
i2amendmentno3tocreditag041.jpg	Edgar Link	pending
i2amendmentno3tocreditag042.jpg	Edgar Link	pending
i2amendmentno3tocreditag043.jpg	Edgar Link	pending
i2amendmentno3tocreditag044.jpg	Edgar Link	pending
i2amendmentno3tocreditag045.jpg	Edgar Link	pending
i2amendmentno3tocreditag046.jpg	Edgar Link	pending
i2amendmentno3tocreditag047.jpg	Edgar Link	pending
i2amendmentno3tocreditag048.jpg	Edgar Link	pending
i2amendmentno3tocreditag049.jpg	Edgar Link	pending
i2amendmentno3tocreditag050.jpg	Edgar Link	pending
i2amendmentno3tocreditag051.jpg	Edgar Link	pending
i2amendmentno3tocreditag052.jpg	Edgar Link	pending
i2amendmentno3tocreditag053.jpg	Edgar Link	pending
i2amendmentno3tocreditag054.jpg	Edgar Link	pending
i2amendmentno3tocreditag055.jpg	Edgar Link	pending
i2amendmentno3tocreditag056.jpg	Edgar Link	pending
i2amendmentno3tocreditag057.jpg	Edgar Link	pending
i2amendmentno3tocreditag058.jpg	Edgar Link	pending
i2amendmentno3tocreditag059.jpg	Edgar Link	pending
i2amendmentno3tocreditag060.jpg	Edgar Link	pending
i2amendmentno3tocreditag061.jpg	Edgar Link	pending
i2amendmentno3tocreditag062.jpg	Edgar Link	pending
i2amendmentno3tocreditag063.jpg	Edgar Link	pending
i2amendmentno3tocreditag064.jpg	Edgar Link	pending
i2amendmentno3tocreditag065.jpg	Edgar Link	pending
i2amendmentno3tocreditag066.jpg	Edgar Link	pending
i2amendmentno3tocreditag067.jpg	Edgar Link	pending
i2amendmentno3tocreditag068.jpg	Edgar Link	pending
i2amendmentno3tocreditag069.jpg	Edgar Link	pending
i2amendmentno3tocreditag070.jpg	Edgar Link	pending
i2amendmentno3tocreditag071.jpg	Edgar Link	pending
i2amendmentno3tocreditag072.jpg	Edgar Link	pending
i2amendmentno3tocreditag073.jpg	Edgar Link	pending
i2amendmentno3tocreditag074.jpg	Edgar Link	pending
i2amendmentno3tocreditag075.jpg	Edgar Link	pending
i2amendmentno3tocreditag076.jpg	Edgar Link	pending
i2amendmentno3tocreditag077.jpg	Edgar Link	pending
i2amendmentno3tocreditag078.jpg	Edgar Link	pending
i2amendmentno3tocreditag079.jpg	Edgar Link	pending
i2amendmentno3tocreditag080.jpg	Edgar Link	pending
i2amendmentno3tocreditag081.jpg	Edgar Link	pending
i2amendmentno3tocreditag082.jpg	Edgar Link	pending
i2amendmentno3tocreditag083.jpg	Edgar Link	pending
i2amendmentno3tocreditag084.jpg	Edgar Link	pending
i2amendmentno3tocreditag085.jpg	Edgar Link	pending
i2amendmentno3tocreditag086.jpg	Edgar Link	pending
i2amendmentno3tocreditag087.jpg	Edgar Link	pending
i2amendmentno3tocreditag088.jpg	Edgar Link	pending
i2amendmentno3tocreditag089.jpg	Edgar Link	pending
i2amendmentno3tocreditag090.jpg	Edgar Link	pending
i2amendmentno3tocreditag091.jpg	Edgar Link	pending
i2amendmentno3tocreditag092.jpg	Edgar Link	pending
i2amendmentno3tocreditag093.jpg	Edgar Link	pending
i2amendmentno3tocreditag094.jpg	Edgar Link	pending
i2amendmentno3tocreditag095.jpg	Edgar Link	pending
i2amendmentno3tocreditag096.jpg	Edgar Link	pending
i2amendmentno3tocreditag097.jpg	Edgar Link	pending
i2amendmentno3tocreditag098.jpg	Edgar Link	pending
i2amendmentno3tocreditag099.jpg	Edgar Link	pending
i2amendmentno3tocreditag100.jpg	Edgar Link	pending
i2amendmentno3tocreditag101.jpg	Edgar Link	pending
i2amendmentno3tocreditag102.jpg	Edgar Link	pending
i2amendmentno3tocreditag103.jpg	Edgar Link	pending
i2amendmentno3tocreditag104.jpg	Edgar Link	pending
i2amendmentno3tocreditag105.jpg	Edgar Link	pending
i2amendmentno3tocreditag106.jpg	Edgar Link	pending
i2amendmentno3tocreditag107.jpg	Edgar Link	pending
i2amendmentno3tocreditag108.jpg	Edgar Link	pending
i2amendmentno3tocreditag109.jpg	Edgar Link	pending
i2amendmentno3tocreditag110.jpg	Edgar Link	pending
i2amendmentno3tocreditag111.jpg	Edgar Link	pending
i2amendmentno3tocreditag112.jpg	Edgar Link	pending
i2amendmentno3tocreditag113.jpg	Edgar Link	pending
i2amendmentno3tocreditag114.jpg	Edgar Link	pending
i2amendmentno3tocreditag115.jpg	Edgar Link	pending
i2amendmentno3tocreditag116.jpg	Edgar Link	pending
i2amendmentno3tocreditag117.jpg	Edgar Link	pending
i2amendmentno3tocreditag118.jpg	Edgar Link	pending
i2amendmentno3tocreditag119.jpg	Edgar Link	pending
i2amendmentno3tocreditag120.jpg	Edgar Link	pending
i2amendmentno3tocreditag121.jpg	Edgar Link	pending
i2amendmentno3tocreditag122.jpg	Edgar Link	pending
i2amendmentno3tocreditag123.jpg	Edgar Link	pending
i2amendmentno3tocreditag124.jpg	Edgar Link	pending
i2amendmentno3tocreditag125.jpg	Edgar Link	pending
i2amendmentno3tocreditag126.jpg	Edgar Link	pending
i2amendmentno3tocreditag127.jpg	Edgar Link	pending
i2amendmentno3tocreditag128.jpg	Edgar Link	pending
i2amendmentno3tocreditag129.jpg	Edgar Link	pending
i2amendmentno3tocreditag130.jpg	Edgar Link	pending
i2amendmentno3tocreditag131.jpg	Edgar Link	pending
i2amendmentno3tocreditag132.jpg	Edgar Link	pending
i2amendmentno3tocreditag133.jpg	Edgar Link	pending
i2amendmentno3tocreditag134.jpg	Edgar Link	pending
i2amendmentno3tocreditag135.jpg	Edgar Link	pending
i2amendmentno3tocreditag136.jpg	Edgar Link	pending
i2amendmentno3tocreditag137.jpg	Edgar Link	pending
i2amendmentno3tocreditag138.jpg	Edgar Link	pending
i2amendmentno3tocreditag139.jpg	Edgar Link	pending
i2amendmentno3tocreditag140.jpg	Edgar Link	pending
i2amendmentno3tocreditag141.jpg	Edgar Link	pending
i2amendmentno3tocreditag142.jpg	Edgar Link	pending
i2amendmentno3tocreditag143.jpg	Edgar Link	pending
i2amendmentno3tocreditag144.jpg	Edgar Link	pending
i2amendmentno3tocreditag145.jpg	Edgar Link	pending
i2amendmentno3tocreditag146.jpg	Edgar Link	pending
i2amendmentno3tocreditag147.jpg	Edgar Link	pending
i2amendmentno3tocreditag148.jpg	Edgar Link	pending
i2amendmentno3tocreditag149.jpg	Edgar Link	pending
i2amendmentno3tocreditag150.jpg	Edgar Link	pending
i2amendmentno3tocreditag151.jpg	Edgar Link	pending
i2amendmentno3tocreditag152.jpg	Edgar Link	pending
i2amendmentno3tocreditag153.jpg	Edgar Link	pending
i2amendmentno3tocreditag154.jpg	Edgar Link	pending
i2amendmentno3tocreditag155.jpg	Edgar Link	pending
i2amendmentno3tocreditag156.jpg	Edgar Link	pending
i2amendmentno3tocreditag157.jpg	Edgar Link	pending
i2amendmentno3tocreditag158.jpg	Edgar Link	pending
i2amendmentno3tocreditag159.jpg	Edgar Link	pending
i2amendmentno3tocreditag160.jpg	Edgar Link	pending
i2amendmentno3tocreditag161.jpg	Edgar Link	pending
i2amendmentno3tocreditag162.jpg	Edgar Link	pending
i2amendmentno3tocreditag163.jpg	Edgar Link	pending
i2amendmentno3tocreditag164.jpg	Edgar Link	pending
i2amendmentno3tocreditag165.jpg	Edgar Link	pending
i2amendmentno3tocreditag166.jpg	Edgar Link	pending
i2amendmentno3tocreditag167.jpg	Edgar Link	pending
i2amendmentno3tocreditag168.jpg	Edgar Link	pending
i2amendmentno3tocreditag169.jpg	Edgar Link	pending
i2amendmentno3tocreditag170.jpg	Edgar Link	pending
i2amendmentno3tocreditag171.jpg	Edgar Link	pending
i2amendmentno3tocreditag172.jpg	Edgar Link	pending
i2amendmentno3tocreditag173.jpg	Edgar Link	pending
i2amendmentno3tocreditag174.jpg	Edgar Link	pending
i2amendmentno3tocreditag175.jpg	Edgar Link	pending
i2amendmentno3tocreditag176.jpg	Edgar Link	pending
i2amendmentno3tocreditag177.jpg	Edgar Link	pending
i2amendmentno3tocreditag178.jpg	Edgar Link	pending
i2amendmentno3tocreditag179.jpg	Edgar Link	pending
i2amendmentno3tocreditag180.jpg	Edgar Link	pending
i2amendmentno3tocreditag181.jpg	Edgar Link	pending
i2amendmentno3tocreditag182.jpg	Edgar Link	pending
i2amendmentno3tocreditag183.jpg	Edgar Link	pending
i2amendmentno3tocreditag184.jpg	Edgar Link	pending
i2amendmentno3tocreditag185.jpg	Edgar Link	pending
i2amendmentno3tocreditag186.jpg	Edgar Link	pending
i2amendmentno3tocreditag187.jpg	Edgar Link	pending
i2amendmentno3tocreditag188.jpg	Edgar Link	pending
i2amendmentno3tocreditag189.jpg	Edgar Link	pending
i2amendmentno3tocreditag190.jpg	Edgar Link	pending
i2amendmentno3tocreditag191.jpg	Edgar Link	pending
i2amendmentno3tocreditag192.jpg	Edgar Link	pending
i2amendmentno3tocreditag193.jpg	Edgar Link	pending
i2amendmentno3tocreditag194.jpg	Edgar Link	pending
i2amendmentno3tocreditag195.jpg	Edgar Link	pending
i2amendmentno3tocreditag196.jpg	Edgar Link	pending
i2amendmentno3tocreditag197.jpg	Edgar Link	pending
i2amendmentno3tocreditag198.jpg	Edgar Link	pending
i2amendmentno3tocreditag199.jpg	Edgar Link	pending
i2amendmentno3tocreditag200.jpg	Edgar Link	pending
i2amendmentno3tocreditag201.jpg	Edgar Link	pending
i2amendmentno3tocreditag202.jpg	Edgar Link	pending
i2amendmentno3tocreditag203.jpg	Edgar Link	pending
i2amendmentno3tocreditag204.jpg	Edgar Link	pending
i2amendmentno3tocreditag205.jpg	Edgar Link	pending
i2amendmentno3tocreditag206.jpg	Edgar Link	pending
i2amendmentno3tocreditag207.jpg	Edgar Link	pending
i2amendmentno3tocreditag208.jpg	Edgar Link	pending
i2amendmentno3tocreditag209.jpg	Edgar Link	pending
i2amendmentno3tocreditag210.jpg	Edgar Link	pending
i2amendmentno3tocreditag211.jpg	Edgar Link	pending
i2amendmentno3tocreditag212.jpg	Edgar Link	pending
i2amendmentno3tocreditag213.jpg	Edgar Link	pending
i2amendmentno3tocreditag214.jpg	Edgar Link	pending
i2amendmentno3tocreditag215.jpg	Edgar Link	pending
i2amendmentno3tocreditag216.jpg	Edgar Link	pending
i2amendmentno3tocreditag217.jpg	Edgar Link	pending
i2amendmentno3tocreditag218.jpg	Edgar Link	pending
i2amendmentno3tocreditag219.jpg	Edgar Link	pending
i2amendmentno3tocreditag220.jpg	Edgar Link	pending
i2amendmentno3tocreditag221.jpg	Edgar Link	pending
i2amendmentno3tocreditag222.jpg	Edgar Link	pending
i2amendmentno3tocreditag223.jpg	Edgar Link	pending
i2amendmentno3tocreditag224.jpg	Edgar Link	pending
i2amendmentno3tocreditag225.jpg	Edgar Link	pending
i2amendmentno3tocreditag226.jpg	Edgar Link	pending
i2amendmentno3tocreditag227.jpg	Edgar Link	pending
i2amendmentno3tocreditag228.jpg	Edgar Link	pending
i2amendmentno3tocreditag229.jpg	Edgar Link	pending
i2amendmentno3tocreditag230.jpg	Edgar Link	pending
i2amendmentno3tocreditag231.jpg	Edgar Link	pending
i2amendmentno3tocreditag232.jpg	Edgar Link	pending
i2amendmentno3tocreditag233.jpg	Edgar Link	pending
i2amendmentno3tocreditag234.jpg	Edgar Link	pending
i2amendmentno3tocreditag235.jpg	Edgar Link	pending
i2amendmentno3tocreditag236.jpg	Edgar Link	pending
i2amendmentno3tocreditag237.jpg	Edgar Link	pending
i2amendmentno3tocreditag238.jpg	Edgar Link	pending
i2amendmentno3tocreditag239.jpg	Edgar Link	pending
i2amendmentno3tocreditag240.jpg	Edgar Link	pending
i2amendmentno3tocreditag241.jpg	Edgar Link	pending
i2amendmentno3tocreditag242.jpg	Edgar Link	pending
i2amendmentno3tocreditag243.jpg	Edgar Link	pending
i2amendmentno3tocreditag244.jpg	Edgar Link	pending
i2amendmentno3tocreditag245.jpg	Edgar Link	pending
i2amendmentno3tocreditag246.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARRY
Array Technologies, Inc. Stock $arry

2023 Q2 Form 10-Q Financial Statement

#000182072123000099 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARRY Array Technologies, Inc. Stock $arry

2023 Q2 Form 10-Q Financial Statement

#000182072123000099 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARRY
Array Technologies, Inc. Stock $arry